- Home
- PHAR vs GNK Comparison
PHAR vs GNK Comparison
Compare PHAR & GNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PHAR | GNK |
|---|---|---|
| Founded | 1988 | 2004 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 732.0M |
| IPO Year | N/A | 2005 |
Fundamental Metrics
Financial Performance| Metric | PHAR | GNK |
|---|---|---|
| Price | $17.87 | $18.27 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $30.00 | $19.00 |
| AVG Volume (30 Days) | 20.3K | ★ 593.0K |
| Earning Date | 11-06-2025 | 11-05-2025 |
| Dividend Yield | N/A | ★ 8.01% |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.00 | N/A |
| Revenue | ★ $362,274,000.00 | $331,332,000.00 |
| Revenue This Year | $24.80 | N/A |
| Revenue Next Year | $6.84 | $4.34 |
| P/E Ratio | $3,084.39 | ★ N/A |
| Revenue Growth | ★ 26.78 | N/A |
| 52 Week Low | $7.50 | $11.20 |
| 52 Week High | $18.12 | $19.60 |
Technical Indicators
Market Signals| Indicator | PHAR | GNK |
|---|---|---|
| Relative Strength Index (RSI) | 60.83 | 50.68 |
| Support Level | $15.76 | $18.64 |
| Resistance Level | $17.35 | $18.98 |
| Average True Range (ATR) | 0.77 | 0.36 |
| MACD | 0.02 | -0.10 |
| Stochastic Oscillator | 89.41 | 5.91 |
Price Performance
Historical ComparisonAbout PHAR Pharming Group N.V.
Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.
About GNK Genco Shipping & Trading Limited New (Marshall Islands)
Genco Shipping & Trading Ltd is an international shipping company specializing in the transportation of iron ore, coal, grain, steel products and other drybulk cargoes. It is involved in the ocean transportation of drybulk cargoes. The company operates in one segment, with two reportable segment: Major and Minor bulk fleet. It generates revenue through time charter agreements, spot market voyage charters, pool agreements and spot market-related time charters. oyage revenues also include the sale of bunkers consumed during short-term time charters pursuant to the terms of the time charter agreement.